Concepedia

J. Shan

JS

5

Publications

454

Citations

5

H-Index

2007

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

J. Shan is an author at The University of Texas MD Anderson Cancer Center specializing in hematology, medicine, and oncology.

Top concepts

MedicineHematologyOncologyHealthGeneticsDiagnosisPathologyPharmacologyCancer ResearchPharmacotherapy

Publications per year

2007–2023

5

Publications

5

A prognostic score for patients with lower risk myelodysplastic syndrome

Guillermo Garcia‐Manero, J. Shan, S. Faderl et al. · Leukemia · 2007 · 316 citations

Hematological Malignancy, Bone Marrow Failure, Prognosis +5

Analysis of outcomes in adolescents and young adults with chronic myelogenous leukemia treated with upfront tyrosine kinase inhibitor therapy

N. Pemmaraju, Hagop Kantarjian, J. Shan et al. · Haematologica · 2012 · 87 citations · Full text

Retrospective comparison of clofarabine versus fludarabine in combination with high-dose cytarabine with or without granulocyte colony-stimulating factor as salvage therapies for acute myeloid leukemia

Pamela S. Becker, Hagop M. Kantarjian, Frederick R. Appelbaum et al. · Haematologica · 2012 · 24 citations · Full text

Hematological Malignancy, Gclac Differs, Oncology +12

Outcome of patients with chronic myeloid leukemia with multiple ABL1 kinase domain mutations receiving tyrosine kinase inhibitor therapy

Alfonso Quintás‐Cardama, Hagop M. Kantarjian, S O'Brien et al. · Haematologica · 2011 · 17 citations · Full text

Hematological Malignancy, Chronic Myeloid Leukemia, Medicine +13

Evaluation of the effects of medium-term (57-day) omeprazole administration and of omeprazole discontinuation on serum gastrin and serum chromogranin A concentrations in the horse

Bethanie Clark, Catherine Steel, Jessica Vokes et al. · Journal of Veterinary Internal Medicine · 2023 · 10 citations · Full text

Rows per page

1–5 of 5